LTC

LTC is a healthcare REIT focused on seniors housing and skilled nursing, and the FY2025 numbers look explosive on the surface — revenue +25.3% to $263M, net income +29.6% to $118M, diluted EPS +23.5% to $2.52. But read the headline against the filing: operating income rose only +2.7% to $205M, and the MD&A confirms why — in Q2 2025 LTC began consolidating a RIDEA/SHOP (seniors housing operating portfolio) segment. SHOP brings gross 'resident fees and services' onto the top line at far lower margins than triple-net rent, so the revenue and P/S figures (7.1x) overstate the economic step-up. Net income is also flattered by gains on the $252.2M of property dispositions over three years. The cleaner lens for a REIT is cash and FFO: operating cash flow of $136M (+8.0%) plus D&A of $37.9M support a normalized FFO in the low-$3-per-share range, putting the stock around 11–12x FFO — fair-to-cheap for a healthcare REIT, and the 15.3x P/E is the wrong yardstick here.

What makes this investable for an income-oriented holder is the combination of a conservative balance sheet and a well-covered, growing payout. Liabilities/equity is just 0.84x and debt-to-assets ~41% — modest for the sector — even after long-term debt rose 23% to $842M to fund the $781.5M of investments underwritten over three years. Dividends paid were $107M (≈$2.21/share, ~5.7% yield), covered by both EPS (~88% payout) and operating cash flow (~79%), and the dividend grew 6.8%. ROE is a respectable 11.0% and the revenue trajectory (FY21 $155M → FY25 $263M) reflects genuine portfolio expansion, not just accounting optics.